Company Overview
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
Key Highlights
- Biotechnology · Healthcare
- Led by Kabir Kumar Nath
- 156 employees
- Based in London, CH
Price History
Loading…
Data from Twelve Data. Prices may be delayed.
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 4
ADP Employment Report
8:15 AM ET
- Nov 5
Initial Jobless Claims
8:30 AM ET
- Nov 6
Employment Situation (NFP)
8:30 AM ET
- Nov 6
G.19 - Consumer Credit
3:00 PM ET
Crypto Prices
View more →
Bitcoin (BTC)
77,657 +1.03%
Company Facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- London, CH, GB
- Incorporated
- Sep 18, 2020
- Website
- compasspathways.com
Latest SEC Filings
View All Filings →- Current Report (Form 8-K)Nov 3, 2026
